Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure
Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the effect of Bemiparin, a low molecular weight
heparin, on implantation rate in women with unexplained recurrent implantation failure
undergoing IVF/ICSI treatment.